Mirae Asset Global Etfs Holdings Ltd. Castle Biosciences Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 14,178 shares of CSTL stock, worth $431,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,178
Previous 13,016
8.93%
Holding current value
$431,578
Previous $283,000
42.76%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
202Shares Held
26MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$92.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$55.6 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$53.2 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$46.8 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$38.4 Million0.61% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $800M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...